Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Pharmacogenomics Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global pharmacogenomics market exhibited moderate growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 7% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Pharmacogenomics is the study of inherited variations in human genes in response to specific drugs. It utilizes the principles of pharmacology and genomics to develop effective and safe medications that are customized to the genetic makeup of an individual. It involves the use of various technologies, such as polymerase chain reaction (PCR), microarray, deoxyribonucleic acid (DNA) sequencing, mass spectrometry and electrophoresis. The genetic tests performed in pharmacogenomics aid in determining the susceptibility to certain diseases and efficacy of the newly developed drugs. Pharmacogenomics is also widely used in the treatment of various diseases, such as cardiovascular, Alzheimer's, cancer, human immunodeficiency virus and acquired immunodeficiency syndrome (HIV/AIDS) and asthma.

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

Pharmacogenomics Market Trends:

Significant growth in the pharmaceutical industry across the globe is one of the key factors creating a positive outlook for the market. Moreover, the increasing demand for precision medicines with enhanced drug safety is providing a thrust to the growth of the market. With the increasing prevalence of chronic lifestyle diseases, there is widespread adoption of targeted drug therapies with minimal side effects and improved efficacy. In line with this, pharmacogenomics is also extensively used for cancer treatments and anticipating the possible drug responses, resistance, efficacy and toxicity of the chemotherapeutic and targeted immune biologic agents, which is also contributing to the market growth. Additionally, various technological advancements, such as the development of pharmacogenomic biomarker labeling solutions, are acting as other growth-inducing factors. They aid in minimizing the risks of avoidable adverse drug reactions (ADRs) in the body and improve clinical outcomes. Other factors, including extensive research and development (R&D) activities, along with significant improvements in the healthcare infrastructure, are anticipated to drive the market toward growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global pharmacogenomics market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on technology, application and end user.

Breakup by Technology:

 

 
 

www.imarcgroup.com

Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.

To get more information about this market, Request Sample

  • Polymerase Chain Reaction
  • Microarray
  • DNA Sequencing
  • Mass Spectrometry
  • Electrophoresis
  • Others
     

Breakup by Application:

  • Oncology
  • Infectious Diseases
  • Cardiovascular Diseases
  • Neurological Diseases
  • Psychiatry
  • Pain Management
  • Others
     

Breakup by End User:

  • Hospitals and Clinics
  • Academic and Research Institutes
     

Breakup by Region:

 

 
 

www.imarcgroup.com

To get more information on the regional analysis of this market, Request Sample

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Bayer AG, Becton Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Illumina Inc., Johnson & Johnson, Merck KGaA, Myriad Genetics Inc., Qiagen N.V. and Thermo Fisher Scientific Inc.

Report Coverage:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Billion
Segment Coverage Technology, Application, End User, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Abbott Laboratories, AstraZeneca plc, Bayer AG, Becton Dickinson and Company, Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, GlaxoSmithKline plc, Illumina Inc., Johnson & Johnson, Merck KGaA, Myriad Genetics Inc., Qiagen N.V. and Thermo Fisher Scientific Inc.
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global pharmacogenomics market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global pharmacogenomics market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end user?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global pharmacogenomics market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Pharmacogenomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Technology
    6.1    Polymerase Chain Reaction
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Microarray
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    DNA Sequencing
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Mass Spectrometry
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Electrophoresis
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7    Market Breakup by Application
    7.1    Oncology
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Infectious Diseases
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Cardiovascular Diseases
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Neurological Diseases
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Psychiatry
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Pain Management
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Others
        7.7.1 Market Trends
        7.7.2 Market Forecast
8    Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Academic and Research Institutes
        8.2.1 Market Trends
        8.2.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    AstraZeneca plc
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Bayer AG
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Becton Dickinson and Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Bio-Rad Laboratories Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    F. Hoffmann-La Roche AG
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    GlaxoSmithKline plc
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Illumina Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Johnson & Johnson
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Merck KGaA
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Myriad Genetics Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Qiagen N.V.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis
        14.3.13    Thermo Fisher Scientific Inc
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio
           14.3.13.3 Financials
           14.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Pharmacogenomics Market: Major Drivers and Challenges
Figure 2: Global: Pharmacogenomics Market: Sales Value (in Billion US$), 2015-2020
Figure 3: Global: Pharmacogenomics Market Forecast: Sales Value (in Billion US$), 2021-2026
Figure 4: Global: Pharmacogenomics Market: Breakup by Technology (in %), 2020
Figure 5: Global: Pharmacogenomics Market: Breakup by Application (in %), 2020
Figure 6: Global: Pharmacogenomics Market: Breakup by End User (in %), 2020
Figure 7: Global: Pharmacogenomics Market: Breakup by Region (in %), 2020
Figure 8: Global: Pharmacogenomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Pharmacogenomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Pharmacogenomics (Microarray) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Pharmacogenomics (Microarray) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Pharmacogenomics (DNA Sequencing) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Pharmacogenomics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Pharmacogenomics (Mass Spectrometry) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Pharmacogenomics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Pharmacogenomics (Electrophoresis) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Pharmacogenomics (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Pharmacogenomics (Other Technologies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Pharmacogenomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Pharmacogenomics (Oncology) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Pharmacogenomics (Oncology) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Pharmacogenomics (Infectious Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Pharmacogenomics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Pharmacogenomics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Pharmacogenomics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Pharmacogenomics (Neurological Diseases) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Pharmacogenomics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Pharmacogenomics (Psychiatry) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Pharmacogenomics (Psychiatry) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Pharmacogenomics (Pain Management) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Pharmacogenomics (Pain Management) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: Global: Pharmacogenomics (Other Applications) Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: Global: Pharmacogenomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: Global: Pharmacogenomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: Global: Pharmacogenomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Global: Pharmacogenomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Global: Pharmacogenomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: North America: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: North America: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: United States: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: United States: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Canada: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Canada: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: Asia-Pacific: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: Asia-Pacific: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: China: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: China: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Japan: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Japan: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: India: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: India: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: South Korea: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: South Korea: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Australia: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Australia: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Indonesia: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Indonesia: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: Others: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: Others: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: Europe: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: Europe: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Germany: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Germany: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: France: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: France: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: United Kingdom: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: United Kingdom: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Italy: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Italy: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Spain: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Spain: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Russia: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Russia: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Others: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Others: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Latin America: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Latin America: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Brazil: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Brazil: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 80: Mexico: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 81: Mexico: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 82: Others: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 83: Others: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 84: Middle East and Africa: Pharmacogenomics Market: Sales Value (in Million US$), 2015 & 2020
Figure 85: Middle East and Africa: Pharmacogenomics Market: Breakup by Country (in %), 2020
Figure 86: Middle East and Africa: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 87: Global: Pharmacogenomics Industry: SWOT Analysis
Figure 88: Global: Pharmacogenomics Industry: Value Chain Analysis
Figure 89: Global: Pharmacogenomics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pharmacogenomics Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Pharmacogenomics Market Forecast: Breakup by Technology (in Million US$), 2021-2026
Table 3: Global: Pharmacogenomics Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Pharmacogenomics Market Forecast: Breakup by End User (in Million US$), 2021-2026
Table 5: Global: Pharmacogenomics Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Pharmacogenomics Market: Competitive Structure
Table 7: Global: Pharmacogenomics Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links